Please login to the form below

Not currently logged in
Email:
Password:

ADA

This page shows the latest ADA news and features for those working in and with pharma, biotech and healthcare.

Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12%

Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12%

Meanwhile, Novo Nordisk presented new data at ADA on its next challenger for a slice of the GLP-1 agonist market, an oral formulation of semaglutide that is currently in a ... Results from phase 3 trials of the drug presented at the ADA found that it was

Latest news

More from news
Approximately 17 fully matching, plus 45 partially matching documents found.

Latest Intelligence

  • The fight for affordable insulin The fight for affordable insulin

    The movement is also distancing itself from some of the big type 1 diabetes advocacy organisations, such as the American Diabetes Association (ADA) and the Juvenile Diabetes Foundation (JDF), which it

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    Ada is an artificial intelligence (AI) app that helps patients navigate quickly and accurately to the right health service and, ultimately, the right diagnosis. ... So far, Ada has performed eight million assessments around the globe, and every three

  • Bluebird: on a mission to ‘recode’ the DNA of healthcare Bluebird: on a mission to ‘recode’ the DNA of healthcare

    GSK’s Strimvelis for ADA-SCID (Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency) followed in 2016, and was a similar commercial failure.

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    pancreatitis. Then GSK’s Strimvelis followed in 2016 for a very rare disease called ADA-SCID (Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency).

  • Translating data to create a meaningful story Translating data to create a meaningful story

    Ada was desperate to work with Charles but as a woman and little-known mathematician it was difficult for her to gain recognition. ... When Ada saw a French article about Charles’s newest idea, she saw her chance.

More from intelligence
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Weekly industry appointments Weekly industry appointments

    There, he is medicines development leader for adenosine deaminase deficiency (ADA-SCID) gene therapy Strimvelis – the first alternative medicine to stem cell transplant for the disease that’s bagged a regulatory

  • Orchard Therapeutics appoints Mark Rothera as CEO Orchard Therapeutics appoints Mark Rothera as CEO

    The clinical data we’ve seen to date with Orchard’s therapy for ADA-SCID is exceptional, and the company has assembled and impressive R&D pipeline to apply the approach

  • Cello Health boosts senior leadership team Cello Health boosts senior leadership team

    He previously served as managing director at Medicom International, an international healthcare publishing firm as well as ADA holdings and ICI Pharmaceuticals.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics